HEALTHFINANCIAL TIMES WORLD
AstraZeneca chief warns group could withhold new drugs in Europe
AstraZeneca chief Pascal Soriot warns that the company may withhold new drugs in Europe unless countries increase spending on innovative medicines following a US trade deal.
Mentioned
Related Signal
Adjacent reporting
- Sandoz warns cheap Chinese imports threaten Europe’s antibiotic supply
- Japan risks losing out without drug pricing reform, warns AstraZeneca CEO
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- Opinion: STAT+: Pharma and biotech leaders are destroying their own industry